Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31425741 | 0.99 | BRD4 (0.32) | BRD4PDCD1CD274CHRNB2CHRNA4 | |
| SCHEMBL2152789 | 0.99 | BRD4 (0.32) | BRD4PDCD1CD274CHRNB2CHRNA4 | |
| Chloromethane SCHEMBL3811082 | 0.96 | BRD4 (0.31) | BRD4PDCD1CD274 | |
| SCHEMBL6435009 | 0.94 | BRD4 (0.30) | BRD4 | |
| SCHEMBL6056183 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL7615751 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL8500783 | 0.89 | — | — | |
| SCHEMBL5906866 | 0.89 | MAOB (0.33) | — | |
| SCHEMBL6056138 | 0.89 | — | — | |
| SCHEMBL4659071 | 0.89 | EDNRB (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4733333-A1 | ETHYLENE/ALFA-OLEFIN COPOLYMER AND APPLICATION THEREOF, AND PACKAGING ADHESIVE FILM COMPOSITION | Wanhua Chemical Group Co., Ltd. (CN) | 2026-04-29 | — | — | EP | disclosed |
| EP-4733332-A1 | ETHYLENE/A-OLEFIN COPOLYMER AND USE THEREOF | Wanhua Chemical Group Co., Ltd. (CN) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025033703-A1 | HIGH-DENSITY ETHYLENE-BASED POLYMER USING HYBRID SUPPORTED CATALYST, AND PREPARATION METHOD THEREOF | 한화솔루션 주식회사 | 2025-02-13 | — | — | WO | disclosed |
| WO-2025033702-A1 | HIGH-DENSITY ETHYLENE-BASED POLYMER USING HYBRID SUPPORTED CATALYST, AND PREPARATION METHOD THEREOF | 한화솔루션 주식회사 | 2025-02-13 | — | — | WO | disclosed |
| US-12139566-B2 | Supported catalyst for propylene polymerization and method for producing polypropylene resin using same | LOTTE CHEMICAL CORPORATION (KR) | 2024-11-12 | — | — | US | disclosed |
| EP-4269453-A1 | HYBRID CATALYST COMPOSITION, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING OLEFIN-BASED POLYMER USING SAME | Hanwha Solutions Corporation (KR) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022139317-A1 | HYBRID CATALYST COMPOSITION, CATALYST COMPRISING SAME, AND METHOD FOR PREPARING OLEFIN-BASED POLYMER USING SAME | 한화솔루션 주식회사 | 2022-06-30 | — | — | WO | disclosed |
| US-20220010044-A1 | SUPPORTED CATALYST FOR PROPYLENE POLYMERIZATION AND METHOD FOR PRODUCING POLYPROPYLENE RESIN USING SAME | LOTTE CHEMICAL CORPORATION (KR) | 2022-01-13 | — | — | US | disclosed |
| EP-3882282-A1 | SUPPORTED CATALYST FOR PROPYLENE POLYMERIZATION AND METHOD FOR PRODUCING POLYPROPYLENE RESIN USING SAME | Lotte Chemical Corporation (KR) | 2021-09-22 | — | — | EP | disclosed |
| US-7674841-B2 | Additive for printing ink, solvent dispersion for printing ink, and printing ink | MITSUI CHEMICALS, INC. (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20070060669-A1 | Additive for printing ink, solvent dispersion for printing ink, and printing ink | MITSUI CHEMICALS, INC. (JP) | 2007-03-15 | — | — | US | disclosed |
| US-6395846-B1 | COORDINATION CATALYST COMPRISING CLAY, ORGANOSILANE COMPOUND, WATER, AND TRANSITION METAL COMPLEX; QUALITY | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-05-28 | — | — | US | disclosed |
| EP-1026176-A1 | CATALYST FOR OLEFIN POLYMER PRODUCTION, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING OLEFIN POLYMER | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220010044-A1 | SUPPORTED CATALYST FOR PROPYLENE POLYMERIZATION AND METHOD FOR PRODUCING POLYPROPYLENE RESIN USING SAME | PPOX, POP1, PPIA | BRD4 3610/4885PDCD1 717/4885CD274 1795/4885 |
| US-12139566-B2 | Supported catalyst for propylene polymerization and method for producing polypropylene resin using same | PPOX, POP1, PPIA | BRD4 3610/4885PDCD1 717/4885CD274 1795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.